Safety, Pharmacokinetics and Pharmacodynamics Study With 2B3-201 in Healthy Subjects and Multiple Sclerosis(MS) Patients

Clinical trial NCT02048358 · TERMINATED

Trial details

NCT number: NCT02048358
Sponsor: BBB-Therapeutics B.V.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers Multiple Sclerosis

Start date: 2013-11-01
Primary completion: 2015-01-01
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.